Emily E Crawford

Biographic Data

ID9063972
NAMEEmily E Crawford
GIVEN NAMESEmily E
FAMILY NAMECrawford
SIGNATURECRAWFORD E E
AFFILIATIONSNigeria Centre for Disease Control
ORCID0000-0003-4645-5724
VERIFIEDYes
TOTAL WORKS6
TOTAL CITATIONS0
WORKS AS AUTHOR6
WORKS AS EDITOR0
FIRST PUBLICATION YEAR1974
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Policies and strategies for HPV vaccination schedule completion in immunocompromised girls, including girls living with HIV

    Open AccessEmily E Crawford, Tosin Ajayi et al.ARTICLEPLOS Global Public Health2026

    Immunocompromised girls, including girls living with HIV, face significantly increased risk for HPV-linked cervical cancer and require a differentiated human papillomavirus (HPV) vaccination schedule. While World Health Organization (WHO) vaccination guidelines exist, recommending immunocompromised individuals receive at least two, if possible three doses of HPV vaccine, little is known about how country health programs implement these recommenda…

  • Insurance Churn and the Covid-19 Pandemic

    Open AccessSarah P Shubeck, Emily Crawford et al.ARTICLEJAMA Health Forum2025

    In this study, the FFCRA was associated with a significantly decreased risk of losing health insurance. Without the FFCRA, an estimated 2.94 million individuals with Medicaid would have lost insurance coverage each year during the COVID-19 public health emergency

  • Effect and cost-effectiveness of human-centred design-based approaches to increase adolescent uptake of modern contraceptives in Nigeria, Ethiopia and Tanzania

    Open AccessCatarina Krug, Melissa Neuman et al.ARTICLEPLOS Global Public Health2023

    Around half of adolescent pregnancies in low- and middle-income countries are unintended, contributing to millions of unsafe abortions per year. Adolescents 360 (A360), a girl-centred initiative, aimed to increase voluntary uptake of modern contraceptives among adolescents in Nigeria, Ethiopia and Tanzania. We evaluated the effectiveness and cost-effectiveness of A360 in increasing modern contraceptive use in selected geographies. We used before-…

  • Covid-19 mortality rate and its associated factors during the first and second waves in Nigeria

    Open AccessKelly Elimian, Anwar Musah et al.ARTICLEPLOS Global Public Health2022

    COVID-19 mortality rate has not been formally assessed in Nigeria. Thus, we aimed to address this gap and identify associated mortality risk factors during the first and second waves in Nigeria. This was a retrospective analysis of national surveillance data from all 37 States in Nigeria between February 27, 2020, and April 3, 2021. The outcome variable was mortality amongst persons who tested positive for SARS-CoV-2 by Reverse-Transcriptase Poly…

  • Nigeria’s public health response to the Covid-19 pandemic

    Open AccessChioma Dan-Nwafor, Chinwe Lucia Ochu et al.ARTICLEJournal of Global Health2020

    The novel coronavirus disease 2019, COVID-19, which is caused by severe acute respiratory syndrome \nvirus 2 (SARS-CoV-2) [1] was first reported in December 2019 by Chinese Health Authorities following an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province [2,3]. SARS-CoV-2 is \nlikely of zoonotic origin, similar to SARS and Middle East Respiratory Syndrome (MERS), and transmitted between humans through respiratory droplets and fomit…

  • An easy developmental screening test for public health use

    L M Armistead, Laura Armistead et al.ARTICLEAmerican Journal of Public Health1974References: 4

    An easy developmental screening test for public health use. L M Armistead, and E E CrawfordCopyRight https://doi.org/10.2105/AJPH.64.3.241 Published Online: October 07, 2011